Summary: The neurological benefits experienced by those with epilepsy who follow ketogenic diets may be a result of the low carb diet lowering brain inflammation, researchers report.
Ketogenic diets — extreme low-carbohydrate, high-fat regimens that have long been known to benefit epilepsy and other neurological illnesses — may work by lowering inflammation in the brain, according to new research by UC San Francisco scientists. The UCSF team has discovered a molecular key to the diet’s apparent effects, opening the door for new therapies that could reduce harmful brain inflammation following stroke and brain trauma by mimicking the beneficial effects of an extreme low-carb diet
“It’s a key issue in the field — how to suppress inflammation in brain after injury,” said Raymond Swanson, MD, a professor of neurology at UC San Francisco, chief of the neurology service at the San Francisco Veterans Affairs Medical Center, and senior author of the new study.
In the paper, published online September 22, 2017 in the journal Nature Communications, Swanson and his colleagues found the previously undiscovered mechanism by which a low carbohydrate diet reduces inflammation in the brain. Importantly, the team identified a pivotal protein that links the diet to inflammatory genes, which, if blocked, could mirror the anti-inflammatory effects of ketogenic diets.
“The ketogenic diet is very difficult to follow in everyday life, and particularly when the patient is very sick,” Swanson said. “The idea that we can achieve some of the benefits of a ketogenic diet by this approach is the really exciting thing here.”
The high-fat, low-carbohydrate regimen of ketogenic diets changes the way the body uses energy. In response to the shortage of carb-derived sugars such as glucose, the body begins breaking down fat into ketones and ketoacids, which it can use as alternative fuels.
In rodents, ketogenic diets — and caloric restriction, in general — are known to reduce inflammation, improve outcomes after brain injury, and even extend lifespan. These benefits are less well-established in humans, however, in part because of the difficulty in maintaining a ketogenic state.
In addition, despite evidence that ketogenic diets can modulate the inflammatory response in rodents, it has been difficult to tease out the precise molecular nuts and bolts by which these diets influence the immune system. Intricate Molecular Waltz
In the new study, the researchers used a small molecule called 2-deoxyglucose, or 2DG, to block glucose metabolism and produce a ketogenic state in rats and controlled laboratory cell lines. The team found that 2DG could bring inflammation levels down to almost control levels.
“I was most surprised by the magnitude of this effect, because I thought ketogenic diets might help just a little bit,” Swanson said. “But when we got these big effects with 2DG, I thought wow, there’s really something here.”
The team further found that reduced glucose metabolism lowered a key barometer of energy metabolism — the NADH/NAD+ ratio — which in turn activated a protein called CtBP that acts to suppress activity of inflammatory genes.
In a clever experiment, the researchers designed a drug-like peptide molecule that blocks the ability of CtBP to enter its inactive state —essentially forcing the protein to constantly block inflammatory gene activity and mimicking the effect of a ketogenic state.
Peptides, which are small proteins, don’t work well themselves as drugs because they are unstable, expensive, and people make antibodies against them. But other molecules that act the same way as the peptide could provide ketogenic benefits without requiring extreme dietary changes, Swanson said.
The study has applications beyond brain-related inflammation. The presence of excess glucose in people with diabetes, for example, is associated with a pro-inflammatory state that often leads to atherosclerosis, the buildup of fatty plaques that can block key arteries. The new study could provide a way of interfering with the relationship between the extra glucose in patients with diabetes and this inflammatory response.
Swanson was joined by current and former UCSF colleagues Stephen M. Massa, MD, PhD; Seok Joon Won; PhD; Ley Hian Low, PhD; Yiguo Shen, PhD, now at Twist Bioscience; David Kapfhamer, PhD, now at Emory University; Angela M. Minnella, PhD, now at BioElectron Technology Corp., Mountain View, Calif.; Ji-Eun Kim, PhD, now at Hallym University, South Korea; Yanting Chen, MD, PhD, now at Nanjing University, China; and Yong Huang, PhD, now at AstraZeneca, in China.
Funding: Funding for the research came from the U.S. Department of Defense, the Department of Veterans Affairs, and the National Institutes of Health.
Source: Devika G Bansal – UCSF Image Source: NeuroscienceNews.com image is credited to Swanson et al./Nature Communications. Original Research: Full open access research for “Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP” by Yiguo Shen, David Kapfhamer, Angela M. Minnella, Ji-Eun Kim, Seok Joon Won, Yanting Chen, Yong Huang, Ley Hian Low, Stephen M. Massa & Raymond A. Swanson in Nature Communications. Published online September 22 2017 doi:10.1038/s41467-017-00707-0
Cite This NeuroscienceNews.com Article
[cbtabs][cbtab title=”MLA”]UCSF “How Ketogenic Diets Curb Inflammation.” NeuroscienceNews. NeuroscienceNews, 22 September 2017. <https://neurosciencenews.com/ketonic-diet-inflammation-7553/>.[/cbtab][cbtab title=”APA”]UCSF (2017, September 22). How Ketogenic Diets Curb Inflammation. NeuroscienceNew. Retrieved September 22, 2017 from https://neurosciencenews.com/ketonic-diet-inflammation-7553/[/cbtab][cbtab title=”Chicago”]UCSF “How Ketogenic Diets Curb Inflammation.” https://neurosciencenews.com/ketonic-diet-inflammation-7553/ (accessed September 22, 2017).[/cbtab][/cbtabs]
Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP
The innate inflammatory response contributes to secondary injury in brain trauma and other disorders. Metabolic factors such as caloric restriction, ketogenic diet, and hyperglycemia influence the inflammatory response, but how this occurs is unclear. Here, we show that glucose metabolism regulates pro-inflammatory NF-κB transcriptional activity through effects on the cytosolic NADH:NAD+ ratio and the NAD(H) sensitive transcriptional co-repressor CtBP. Reduced glucose availability reduces the NADH:NAD+ ratio, NF-κB transcriptional activity, and pro-inflammatory gene expression in macrophages and microglia. These effects are inhibited by forced elevation of NADH, reduced expression of CtBP, or transfection with an NAD(H) insensitive CtBP, and are replicated by a synthetic peptide that inhibits CtBP dimerization. Changes in the NADH:NAD+ ratio regulate CtBP binding to the acetyltransferase p300, and regulate binding of p300 and the transcription factor NF-κB to pro-inflammatory gene promoters. These findings identify a mechanism by which alterations in cellular glucose metabolism can influence cellular inflammatory responses.
“Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP” by Yiguo Shen, David Kapfhamer, Angela M. Minnella, Ji-Eun Kim, Seok Joon Won, Yanting Chen, Yong Huang, Ley Hian Low, Stephen M. Massa & Raymond A. Swanson in Nature Communications. Published online September 22 2017 doi:10.1038/s41467-017-00707-0